Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Pathology

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.875PMID 11400144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of chromosomal imbalances in invasive breast cancer

  2000cited by this paper
• Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.

  2000cited by this paper
• Pulmonary adenocarcinoma metastatic to pituitary craniopharyngioma

  2000cited by this paper
• Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast

  2000cited by this paper
• Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.

  1999cited by this paper
• Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways

  1999influential reference
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes

  1999cited by this paper
• Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

  1999influential reference
• Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

  1999influential reference
• Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.

  1999cited by this paper
• Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.

  1998cited by this paper
• High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

  1998cited by this paper
• Molecular cytogenetics of primary breast cancer by CGH

  1998cited by this paper
• Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.

  1998cited by this paper
• Genetic analysis of 53 lymph node‐negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

  1998cited by this paper
• Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: Results from the multicenter morphometric mammary carcinoma project (MMMCP)

  1997cited by this paper
• Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

  1997cited by this paper
• Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.

  1997cited by this paper
• Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases.

  1996cited by this paper
• Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.

  1996cited by this paper
• Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas.

  1995cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

  1995cited by this paper
• Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma

  1995cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Ductal carcinoma in situ: a proposal for a new classification.

  1994influential reference
• Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.

  1994cited by this paper
• Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation.

  1993cited by this paper
• Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.

  1993cited by this paper
• Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up

  1992cited by this paper
• Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project.

  1992cited by this paper
• The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients.

  1991cited by this paper
• Tumours of the Breast

  1962cited by this paper
• Tumours of the Breast

  1894cited by this paper

• Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.

  2022cites this paper
• Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRAS) and Gain of Chromosome 1q

  2020cites this paper
• Intraductal Proliferative Disease of the Breast

  2019cites this paper
• A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients

  2019cites this paper
• Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast

  2018cites this paper
• Mechanostimulation of integrin αvβ6 and fibronectin in DCIS myoepithelial cells

  2018influential citation
• Ductal Carcinoma in Situ of the Breast

  2018influential citation
• The Spectrum of Risk Lesions in Breast Pathology: Risk Factors or Cancer Precursors?

  2018cites this paper
• DCIS: Pathology and Biological Features

  2018cites this paper
• Is DCIS Overrated?

  2018cites this paper
• INVESTIGATING INVASION IN DUCTAL CARCINOMA IN SITU WITH TOPOGRAPHICAL SINGLE CELL GENOME SEQUENCING

  2018cites this paper
• Molecular Classification of Lobular Carcinoma of the Breast

  2017cites this paper
• Grading of Invasive Carcinoma

  2017cites this paper
• Genome evolution in ductal carcinoma in situ: invasion of the clones

  2017cites this paper
• The diagnostic challenge of low-grade ductal carcinoma in situ.

  2017cites this paper
• Pathology and Molecular Pathology of Breast Cancer

  2017cites this paper
• Differential expression of cellular senescence markers in the assessment of breast cancer development

  2016cites this paper
• Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion

  2016cites this paper
• Understanding the functions of the novel oncogene SHON in breast cancer

  2015cites this paper
• Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade

  2015cites this paper
• 8p deletion is strongly linked to poor prognosis in breast cancer

  2015cites this paper
• Molecular Pathology of Precancerous Lesions of the Breast

  2015cites this paper
• Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.

  2014cites this paper
• Narrowing down the focus: what are the main predictive markers for ductal carcinoma in situ?

  2014cites this paper
• Aberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: A pilot study

  2014cites this paper
• Pathology and Biological Markers of Invasive Breast Cancer

  2014cites this paper
• Au-delà du cerveau : une importance majeure de la huntingtine et de sa phosphorylation à la sérine 421 dans les cancers du sein

  2014cites this paper
• Breast cancer precursors: diagnostic issues and current understanding on their pathogenesis

  2013cites this paper
• Breast carcinoma: is molecular evaluation a necessary part of current pathological analysis?

  2013cites this paper
• Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.

  2013cites this paper
• Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma

  2013influential citation
• Karzinogenese der Mammakarzinome

  2013cites this paper
• Influence of the in situ component in 389 infiltrating ductal breast carcinomas

  2013cites this paper
• Breast Cancer Diagnosis in the Molecular Era-Morphology Matters !

  2013cites this paper
• Functional Characterisation of Glycosyltransferase 1 Domain Containing 1 gene in Mammary Carcinoma Cells

  2013influential citation
• Use of Protein Biomarkers for the Early Detection of Breast Cancer

  2013cites this paper
• Progression of Early Breast Cancer to an Invasive Phenotype

  2013cites this paper
• Ductal Carcinoma in Situ Treatment Requires a Multidisciplinary Approach

  2013cites this paper
• The low nuclear grade breast neoplasia family

  2012cites this paper
• Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification

  2012cites this paper
• ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas

  2012cites this paper
• The r ole of non-canonical Wnt/planar cell polarity signalling in breast cancer progression

  2012cites this paper
• Genotyping and Phenotyping of Male Breast Cancer

  2012cites this paper
• Evaluation of Genetic Status of HER-2/neu and Aneusomy 17 by Fluorescence In Situ Hybridization and Comparison with Immunohistochemistry Assay from Indian Breast Cancer Patients

  2012cites this paper
• Invasive Ductal Carcinoma of No Special Type and Histologic Grade

  2012cites this paper
• Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study

  2012cites this paper
• Morphological and immunohistochemical characteristics of triple negative and basal breast carcinoma

  2012cites this paper
• Tumorigenesis and Neoplastic Progression Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of MYC during Progression

  2012cites this paper
• Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?

  2012cites this paper
• Is There a Low-Grade Precursor Pathway in Breast Cancer?

  2012cites this paper
• Transcriptomic landscape of breast cancers through mRNA sequencing

  2012cites this paper
• The Molecular Evolution of Breast Cancer Precursors and Risk Indicators

  2011cites this paper
• Low-grade and high-grade invasive ductal carcinomas of the breast follow divergent routes of progression

  2011cites this paper
• Proteomics-Based Disease Biomarkers

  2011cites this paper
• Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor‐positive, invasive breast cancer

  2011cites this paper
• Biologic characteristics of premalignant breast disease

  2011cites this paper
• Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study

  2011cites this paper
• Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer

  2011cites this paper
• Protein Biomarkers for the Early Detection of Breast Cancer

  2011cites this paper
• Bidirectional signaling of mammary epithelium and stroma: implications for breast cancer--preventive actions of dietary factors.

  2011cites this paper
• Monomorphic epithelial proliferations of the breast: a possible precursor lesion associated with ipsilateral breast failure after breast conserving therapy in patients with negative lumpectomy margins.

  2011cites this paper
• The molecular pathology of breast cancer progression

  2011cites this paper
• Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology

  2010cites this paper
• Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer

  2010cites this paper
• Molecular classification of breast carcinomas

  2010cites this paper
• Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients

  2010cites this paper
• Preinvasive breast cancer.

  2010influential citation
• Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study

  2010cites this paper
• Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype‐matched ductal and lobular carcinomas

  2010cites this paper
• Ductal carcinoma in situ: Current concepts

  2010cites this paper
• Breast cancer precursors revisited: molecular features and progression pathways

  2010cites this paper
• DNA amplifications in breast cancer: genotypic-phenotypic correlations.

  2010cites this paper
• Biomarkers in breast cancer.

  2010cites this paper
• Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.

  2009cites this paper
• Mixed micropapillary–ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components

  2009cites this paper
• Genomweite Expressionsprofile als klinische Entscheidungshilfe

  2009cites this paper
• [Genome-wide expression profiling as a clinical tool: are we there yet?].

  2009cites this paper
• Molecular pathology of Invasive Lobular Breast Carcinoma

  2009cites this paper
• Genomic Heterogeneity of Breast Tumor Pathogenesis

  2009cites this paper
• Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet?

  2009cites this paper
• Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?

  2009influential citation
• Molecular Changes in Primary Breast Tumors and the Nottingham Histologic Score

  2009cites this paper
• Noninvasive Imaging of Breast Cancer

  2009cites this paper
• An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.

  2008cites this paper
• Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

  2008cites this paper
• Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

  2008cites this paper
• Chromosomal Alterations Associated with the Transition from In Situ to Invasive Breast Cancer

  2008cites this paper
• Nm23-H1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis.

  2008cites this paper
• Basal carcinoma of the breast revisited: an old entity with new interpretations

  2008cites this paper
• Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.

  2008cites this paper
• Breast cancer special types: why bother?

  2008cites this paper
• The molecular journey from ductal carcinoma in situ to invasive breast cancer

  2008cites this paper
• Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

  2008cites this paper
• Oncogenic pathways in hereditary and sporadic breast cancer.

  2008cites this paper
• Comparative genomic hybridization (CGH) analysis of chromosomal aberrations in Iranian patients with invasive ductal carcinoma breast cancer.

  2008cites this paper
• Molecular regulation of breast cancer susceptibility by dietary factors

  2008cites this paper
• Molecular diagnosis in breast cancer

  2008cites this paper
• Genomic signatures of cancer progression: from in vitro experimental models to prediction of human breast cancer outcome.

  2008cites this paper
• Nm23-H1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis

  2008cites this paper
• Reprint of Oncogenic pathways in hereditary and sporadic breast cancer

  2008cites this paper